67 Epidermolysis bullosa acquisita Lawrence S. Chan Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Epidermolysis bullosa…
47 Cryptococcosis Wanda Sonia Robles and Mahreen Ameen Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Cryptococcosis…
42 Chondrodermatitis nodularis helicis chronicus Clifford M. Lawrence Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Chondrodermatitis…
60 Discoid lupus erythematosus Bruce H. Thiers Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Discoid lupus…
37 Cat scratch disease Adam H. Wiener, Bryan A. Selkin and George J. Murakawa Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥…
43 Chromoblastomycosis Wanda Sonia Robles and Mahreen Ameen Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Chromoblastomycosis…
68 Erosive pustular dermatosis Bhavnit K. Bhatia and Jenny E. Murase Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
15 Antiphospholipid syndrome Julia S. Lehman and Mark D.P. Davis Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case…
31 Bowen’s disease and erythroplasia of Queyrat Thomas D. Regan and Naomi Lawrence Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5…
54 Dermatitis artefacta Jillian W. Wong Millsop and John Y.M. Koo Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
